OnsiteGene Inc launches the XDive five-minute real-time PCR instrument
Ultra-fast real-time PCR analysis platform that integrates high-speed thermal cycling, ultra-fast PCR reaction reagents, and real-time fluorescence data acquisition workflows
30 Jul 2024
OnsiteGene Inc., a member of the NIH RADx initiative, has launched XDive™, the world's first five-minute real-time PCR instrument. It completes 40 thermal cycles and real-time fluorescent imaging in just five minutes while maintaining sensitivity comparable to other brands on the market.
XDive is capable of processing 16 samples and up to 64 multiplexing targets per run. The instrument has received FDA Emergency Use Authorization (EUA) for COVID-19 and Monkeypox testing using swab or saliva samples. XDive's editable panel technology simplifies the regulatory process for developing test kits and syndromic panels, significantly reducing time, cost, and risk.
The master mix used in the XDive instrument is in a dried form, allowing for easy shipping and storage at room temperature with a shelf life of six months.
OnsiteGene has also developed the XPrep module, designed to extract RNA/DNA and load XDive cartridges. With the XPrep module, XDive instruments provide a comprehensive and flexible sample-to-answer platform with up to 96-sample throughput, up to 256 multiplexing targets, and a 30-minute turnaround time.
OnsiteGene will be at ADLM 2024 Clinical Lab Expo in Chicago, USA, meet the team at Booth #1047.
Want the latest science news straight to your inbox? Become a SelectScience member for free today>>